UK-CAB 65: BHIVA/BASHH feedback; Treatment as/for prevention

Saturday 21 April 2018

Please note:

This meeting will take place in Edinburgh, to take advantage of the BHIVA/BASHH conference. The meeting will focus on Guidelines feedback, in relation to quality of life: community reps for guidelines will provide feedback.


09.15-09.30 Arrival, tea and refreshments
09.30-10.00 Welcome and introductions, UK-CAB updates, company pre-meeting
10.00-11.30 Company meeting: MSD
11.30-11.45 BREAK
11.45-12.45 Conference feedback – clinical perspective – Prof. Clifford Leen, Western General Hospital
12.45-14.00 LUNCH


Treatment as/for prevention

·       Pregnancy guidelines

·       Sexual reproduction health

·       U=U discussion feedback

15.30-15.45 BREAK


Conferences feedback – CROI

BHIVA/BASHH Conference community feedback – speakersReflection and feedback of the meeting member updates

16.30 Meeting close

 Background reading – to follow


Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.


Published: May 9, 2017
Last edited: March 15, 2018